September 4th 2025
The financing supports phase 3 evaluation of SIDIPREV, a first-in-class, non-antibiotic therapy designed to prevent C difficile infections, a leading US health care–associated threat.
Developing a Risk Prediction Model for Health Care-Associated C Diff Infection
December 16th 2019A team of investigators set out to identify whether a risk prediction model that was developed at Novant Health could accurately identify individuals at a high-risk for health care-associated C diff infection.
Read More
Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score
The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.
Read More